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1. Introduction
   Staphylococcus aureus (S. aureus) is perhaps the greatest 
concern of human pathogens because of its intrinsic virulence 
because of its ability to cause a diverse array of life-
threatening infections and its capacity to adapt to different 
environmental conditions[1-3]. Nowadays, this organism is the 
leading overall cause of health-care associated infections 
globally and, as more patients are treated outside the hospital 
settings, is an increasing concern in the community[4,5]. There 
are many anti-staphylococcal drugs, including methicillin, 
tetracyclines, fluoroquinolones, linezolid and daptomycin, 
but they quickly loss their therapeutic value due to the 
ability of the bacterium to develop effective mechanisms to 
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Objective: To evaluated the PCR for mecA gene compared with the conventional oxacillin disk 
diffusion method for methicillin-resistant Staphylococcus aureus (S. aureus) identification.
Methods: A total of 292 S. aureus strains were isolated from various clinical specimens obtained 
from hospitalized patients. Susceptibility test to several antimicrobial agents was performed by 
disk diffusion agar according to Clinical and Laboratory Standards Institute guidelines. The PCR 
amplification of the mecA gene was carried out in all the clinical isolates.
Results: Among antibiotics used in our study, penicillin showed the least anti-staphylococcal 
activity and vancomycin was the most effective. The rate of methicillin-resistant S. aureus 
prevalence determined by oxacillin disk diffusion method was 47.6%; whereas, 45.1% of S. aureus 
isolates were mecA- positive in the PCR assay.
Conclusions: This study is suggestive that the PCR for detection of mecA gene is a fast, accurate 
and valuable diagnostic tool, particularly in hospitals in areas where methicillin-resistant S. 
aureus is endemic.
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Comments
This is a valuable investigation in 
which authors identified clinical 
isolates of MRSA using two methods 
and determined their antimicrobial 
resistance patterns. The results 
propose that PCR assay for mecA gene 
is the best method for detecting true 
methicillin resistance in S. aureus.
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confront these agents[1,6]. 
   Methicillin-resistant S. aureus (MRSA) strains have been 
recognized as serious nosocomaial infections and have spread 
worldwide that this in turn has an extensive impact on patient 
managing in health care settings and results in enormous 
increases in health care costs[7].
   S. aureus acquires methicillin resistance by insertion of 
staphylococcal cassette chromosome (SCCmec), carrying the 
mecA gene, into chromosome. This gene encodes an altered 
penicillin-binding protein, PBP-2a, which is not inhibited 
by existing b-lactam antibiotics[8-10].
   There are several antimicrobial susceptibility methods 
for detection of MRSA, including oxacillin screening 
test, oxacillin and/or cefoxitin disk diffusion method 
and oxacil l in minimum inhibitory concentration 
test[11-13]. There are many reports that these conventional 
antimicrobial tests are associated with false negative 
and positive results for MRSA identification. Therefore, 
it is necessary to use more exact and specific methods, 
such as PCR that is considered as a DNA-based assay. As 
respects there is no mecA gene in methicillin-sensitive S. 
aureus (MSSA) strains, detection of this gene in any isolates 
of S. aureus is indicative of MRSA[14]. In this regard, we 
conduct the present investigation to compare oxacillin disk 
diffusion (ODD) method and PCR assay for identification of 
true methicillin-resistant strains of S. aureus from clinical 
specimens collected from three large hospitals in Tehran, 
Iran. 
2. Material and methods
2.1. Clinical specimens and laboratory identification
   In a period of 9 month, various clinical samples, 
including blood, urine, skin lesions, sputum, intratracheal 
tube, cerebrospinal fluid, synovial fluid and pus were 
obtained from patients of three large teaching hospitals of 
Tehran and then, transferred to the laboratory by brain-
heart infusion broth medium. Each sample was cultured 
on mannitol salt agar (Merck Co., Germany) and incubated 
in 37 °C for 24 h. Then, all suspected S. aureus colonies 
were plated onto blood agar. Identification of S. aureus 
suspicious grown colonies was based on Gram staining 
and standard biochemical reactions, including catalase, 
coagulase, and novobiocin sensitivity tests.     
2.2. Antimicrobial susceptibility testing
   Susceptibility of clinical isolates to 10 antibiotics (Mast, 
Merseyside, UK), including penicillin (10 µg), oxacillin (1 
µg), vancomycin (30 µg), cefalotin (30 µg), gentamicin (10 µg), 
tetracycline (30 µg), erythromycin (15 µg), clindamaycin (2 µg), 
ciprofloxacin (5 µg) and co-trimoxazole (25 µg) was evaluated 
by agar disk diffusion method on Mueller-Hinton agar plates, 
as recommended by Clinical and Laboratory Standards 
Institute (CLSI)[15]. S. aureus ATCC 29213 was used as control 
strain for disk susceptibility testing.
2.3. Detection of mecA gene by PCR technique 
   The standard PCR assay was performed using the 
DNA amplification instrument Mastercycler gradient 
(Eppendorf, Germany) to identify MRSA strains. Cellular 
DNA was obtained from Staphylococci colonies grown 
overnight on blood agar plates using DNA Extraction Kit 
(Bioneer Co., Korea) in accordance with manufacturer’s 
instructions. The mecA- specific primer pairs used for 
amplification of 533 base pair (bp) fragment are Forward, 
5’-AAAATCGATGGTAAAGGTTGGC-3’, and Reverse, 5’-
AGTTCTGGAGTACCGGATTTGC-3’[16]. A volume of 1 µL of 
prepared DNA (0.5 µg) was added to a final volume of 25 µL 
PCR mixture containing 10 µL of 2伊 Master Mix (Ampliqon, 
Denmark), including 1伊 PCR buffer, 1.5 mmol/L MgCl2, 0.15 
mmol/L dNTP, and 1.25 IU Taq DNA polymerase, (Ampliqon 
Co., Denmark), 0.7 µL of 0.8 µmol/L each primer and 12.6 µL 
of sterile distilled water. The thermal cycling protocol for 
PCR was comprised 95 °C for 3 min, followed by 33 cycles of 
94 °C for 1 min, 53 °C for 30 s and 72 °C for 1 min, with a final 
extension at 72 °C for 6 min. The amplified products were 
visualized by electrophoresis in 2% agarose gels stained with 
ethidium bromide.  
3. Results
3.1. Bacterial isolates
   Overall, 292 S. aureus strains were recovered from obtained 
clinical samples. The distribution analysis of the S. aureus 
isolates showed that the most isolates (29.0%) were recovered 
from the pus and the lowest (1.4%) found to be isolated from 
cerebrospinal fluid (Table 1). The prevalence of MRSA found 
using antibiotic sensitivity test (ODD), were 47.6% (133/279). 
The highest rate of oxacillin-resistant S. aureus was 
recovered from blood samples (49.2%).
3.2. Antibiotic resistance profiles
   The antimicrobial susceptibility testing by agar disk diffusion 
method among S. aureus isolates determined that the percentage 
of resistance to penicillin, cefalotin, gentmicin, tetracycline, 
erythromycin, oxacillin, co-trimoxazole, clindamaycin, 
ciprofloxacin and vancomycin were 100%, 47.6%, 49.1%, 59.1%, 
50%, 47.6%, 48.3%, 25%, 57.7% and 0.7%, respectively (Table 1). 
The highest rate of resistance among oxacillin-resistant S. 
aureus was related to penicillin with 100% frequency. Except for 
two strains, all MRSA isolates were susceptible to vancomycin.
3.3. PCR amplification of mecA gene
   Identification of MRSA strains was performed by detection of 
mecA gene in all S. aureus strains using PCR assay. The results 
revealed that 45.1% (126/279) of Staphylococci isolates carried 
mecA gene. The PCR-amplified DNA products of this gene 
of five selected clinical isolates are shown in Figure 1. The 
antimicrobial resistance pattern of mecA-positive and negative 
strains is shown in Table 2. 
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Figure 1. PCR amplification of mecA gene in five selected isolates of S. 
aureus.
Lane C-: mecA negative S. aureus; Lane 1-5: PCR product of mecA gene (533 
bp); M: 100 bp DNA size marker.
4. Discussion
   During the last decade, MRSA strains have emerged as serious 
nosocomial pathogens and spread in many regions of world 
because of its ability to acquiring resistance to antimicrobial 
chemotherapy[9,17]. Therefore, rapid recognition of these 
organisms and detection of methicillin resistance are essential 
for prompting effective therapy, preventing distribution of 
infection and reducing the risk of patient’s mortality[18,19].
   The susceptibility test profile obtained in the present study 
showed that a significant percentage of S. aureus isolates were 
resistant to most of the commonly used antibiotics, as similar to 
other studies[12,19-21]. All Staphylococci exhibited resistance to 
penicillin, while 99.3% of strains were sensitive to vancomycin 
and this the emergence of vancomycin-resistant S. aureus, 
although a few in number, is alarming. It should be noted that 
both vancomycin-resistant S. aureus isolates found in our study 
were belong to MRSA strains confirmed by PCR. This may be 
mainly due to the antibiotic abuse and selective pressure of 
vancomycin, as a main antibiotic available for the treatment of 
severe and life threatening infections caused by MRSA. 
   Our results indicated that the rate of antimicrobial resistance 
among mecA-positive compared with mecA-negative 
Staphylococci is more. These findings are consistent to the 
other studies[19-21], and support the fact that the MRSA isolates 
frequently carry resistance gene to other antibacterial agents. 
The rate of MRSA prevalence by ODD method was 47.6% (133/279); 
whereas, 45.1% of S. aureus isolates were identified as MRSA 
using PCR assay. The ODD method was performed according 
to CLSI guidelines using the S. aureus ATCC 29213 reference 
strain. However, 7 strains of all 133 S. aureus isolates that were 
found as MRSA by this method had no mecA gene in PCR assay. 
This finding has also been reported by Cekovska et al.[22] and 
Davoodi and coworkers[18]. Based on other studies, the ODD test 
usually shows false negative results and its sensitivity is low, 
especially for the strains with heterogeneous resistance[11,23-25]. 
Findings of our investigation indicate that the ODD method can 
also be associated with false-positive results, as consistent 
as other studies[19,25]. In general, accurate determination of 
methicillin resistance in S. aureus by conventional laboratory 
Table 2
Antibiotic resistance in mecA-positive and mecA-negative S. aureus isolates using PCR method.
S. aureus isolates
No. of antimicrobial resistance [n (%)]
PEN TET GM KF ERY CD TS CIP VAN
mecA-positive 126 (100) 73 (57.9) 81 (64.2) 70 (55.5) 79 (62.7) 35 (27.7) 71 (56.3) 80 (63.5) 2 (1.6)
mecA-negative 153 (100) 65 (42.4) 52 (33.9) 64 (41.8) 26 (17.6) 8 (5.2) 39 (30.9) 73 (47.7) 0 (0.0)
PEN: Penicillin, TET: Tetracyclin, GM: Gentamicin, KF: Cefalotin, ERY: Erythromycin, CD: Clindamaycin, TS: Co-trimoxazole, CIP: Ciprofloxacin, 
VAN: Vancomycin.
Table 1
Antibiotic resistance profile of S. aureus isolates.
Origin sample
No. of S. aureus isolates 
[n (%)]
No. (%) of antimicrobial resistance
PEN OXA TET GM KF ERY CD TS CIP VAN
Blood 65 (23.2) 65 (100) 32 (49.2) 41 (63.0)  37 (56.9)   30 (46.1) 38 (58.4) 21 (32.3)  29 (44.6)   38 (58.4) 1 (1.5)
Urine  46 (16.5) 46 (100) 17 (36.9) 28 (60.8)  30 (65.2)   19 (41.3) 18 (39.1)   8 (17.4)  23 (50.0)   20 (43.4) 0 (0.0)
Skin lesions   39 (13.9) 39 (100) 15 (38.4) 16 (41.0)  18 (46.1)   15 (38.4) 15 (38.4)   9 (23.0)  16 (41.0)   23 (58.9) 0 (0.0)
Sputum 14 (5.0) 14 (100)   2 (14.3)   8 (57.1)    6 (42.8)    7 (50.0)   8 (57.1)   5 (35.7)   8 (57.1)    8 (57.1) 0 (0.0)
Intratracheal tube 17 (6.0) 17 (100)   8 (47.0)   9 (53.0)    5 (29.4)    7 (41.1)  10 (70.5)   2 (11.7)  10 (58.8)    9 (52.9) 0 (0.0)
Cerebrospinal fluid  4 (1.4)  4 (100) 0 (0.0)   1 (25.0)    2 (50.0)    1 (25.0)   1 (25.0)   1 (25.0)   3 (75.0)    2 (50.0) 0 (0.0)
Synovial fluid  12 (4.3) 12 (100)   2 (16.6)   6 (50.0)    3 (25.0)    6 (50.0)   4 (41.6)   4 (33.3)   5 (41.6)    6 (50.0) 0 (0.0)
Pus  82 (29.0) 82 (100)  37 (45.1)  56 (68.2)   36 (43.9)   48 (58.5)  45 (54.8) 20 (24.4)  41 (50.0)   55 (67.0) 1 (1.2)
Total  279 (100.0) 279 (100) 133 (47.6) 165 (59.1) 137 (49.1) 133 (47.6) 139 (50.0) 70 (25.0) 135 (48.3) 161 (57.7) 2 (0.7)
PEN: Penicillin, OXA: Oxacillin, TET: Tetracyclin, Gm: Gentamicin, KF: Cefalotin, ERY:  Erythromycin, CD: Clindamaycin, TS: Co-trimoxazole, 
CIP: Ciprofloxacin, VAN: Vancomycin.
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tests is subject to variations, including inoculum size, diameter, 
pH and salt concentration of medium, incubation time, etc. 
In such circumstances, detection of mecA gene by molecular 
methods, including the gold standard PCR technique is very 
helpful and valuable. It seems that the ODD test-positive, 
but PCR-negative isolates would be penicillinase hyper 
producer that hydrolyze the penicillinase-resistant penicillins. 
Susceptibility tests to oxacillin in these strains, namely 
“borderline oxacillin-resistant S. aureus”, show reduction 
or borderline in susceptibility. However, the borderline 
phenotypes have been attributed to other mechanisms: 
production of an inducible, plasmid-mediated methicillinase or 
different alterations in the penicillin-binding protein genes due 
to spontaneous amino acid substitutions in the transpeptidase 
domain[26,27]. Distinguish of these low level resistant bacteria 
by routine tests from true resistant strains that harbor mecA 
gene may be difficult. In the other hand, the clinical dilemma 
posed by borderline oxacillin-resistant S. aureus strains is that 
during beta-lactam chemotherapy, production of PBP-2a may 
be induced, converting them into oxacilline-resistant strains. 
So, detection of mecA gene is required for precise differentiation 
of MRSA and the PCR can be used as a useful method in clinical 
laboratories.
   In conclusion, our study indicates that PCR assay is a easy and 
reliable tools for detection of MRSA from patients and carrier 
individuals. On the other hand, with respect to the emergence of 
multidrug resistant MRSA strains, rapid identification and timely 
treatment of their infections help to reduce the mortality and 
avoid the spread of these organisms.
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Comments 
Background
   Currently, methicillin-resistant S. aureus (MRSA) is 
considered as a notorious etiologic agent for a various 
infections and a leading cause of nosocomial infections 
worldwide. The even greater concern is that the spread of 
these bacteria is able to evolve resistance to all members 
of the β-lactam family. Therefore, rapid reporting of 
identification and antibiogram results can be conducted to 
good outcomes for patients infected by these pathogens.
  
Research frontiers
   The increased incidence of MRSA and its antibiotic 
resistance are the major health problems in Iran. This 
research work was primarily done to compare the 
performance of MRSA-specific and rapid PCR assay with 
that of the conventional ODD method to identify true MRSA 
isolates. Moreover, the work is a epidemiological study 
regarding susceptibility patterns of these bacteria.
Related reports
   The false positive results obtained by the conventional 
ODD test in the present study have also been reported by 
Cekovaska et al. (2005) in Republic of Macedonia.
Innovations and breakthroughs
   This is a comprehensive survey on the antimicrobial 
susceptibility profiles of MRSA strains isolated from wide 
variety clinical specimens in three hospitals of Tehran. On 
the other hand, in Iran, like other countries, antimicrobial 
susceptibility methods are frequently used for MRSA 
identification which are associated with false positive and 
negative results. In the present study, authors indicated that 
PCR is the gold standard technique for detecting MRSA. 
  
Applications
   Rapid detection of clinical isolates of MRSA by easy and 
reliable tools such as PCR is of key importance in prevention 
and prognosis of infections caused by these recalcitrant 
bacteria. Beside this, it would be helpful to infectious 
specialist inform updated susceptibility data in S. aureus 
isolates for opting a proper antibiotics.    
Peer review
   This is a valuable investigation in which authors identified 
clinical isolates of MRSA using two methods and determined 
their antimicrobial resistance patterns. The results propose 
that PCR assay for mecA gene is the best method for detecting 
true methicillin resistance in S. aureus.
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